These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30794360)

  • 1. Systemic Therapies for Moderate-to-Severe Atopic Dermatitis: Expert Perspectives in Practice.
    Lebwohl M; Alexis AF; Beck LA; Block JK; Eichenfield LF; Fonacier L; Guttman-Yassky E; Paller AS; Pariser D; Silverberg JI; Boguniewicz M
    J Drugs Dermatol; 2019 Feb; 18(2):122-129. PubMed ID: 30794360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and management of moderate to severe adult atopic dermatitis: a Consensus by the Italian Society of Dermatology and Venereology (SIDeMaST), the Italian Association of Hospital Dermatologists (ADOI), the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC), and the Italian Society of Allergological, Environmental and Occupational Dermatology (SIDAPA).
    Calzavara Pinton P; Cristaudo A; Foti C; Canonica GW; Balato N; Costanzo A; DE Pità O; DE Simone C; Patruno C; Pellacani G; Peris K; Girolomoni G
    G Ital Dermatol Venereol; 2018 Apr; 153(2):133-145. PubMed ID: 29237258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expert Perspectives on Management of Moderate-to-Severe Atopic Dermatitis: A Multidisciplinary Consensus Addressing Current and Emerging Therapies.
    Boguniewicz M; Alexis AF; Beck LA; Block J; Eichenfield LF; Fonacier L; Guttman-Yassky E; Paller AS; Pariser D; Silverberg JI; Lebwohl M
    J Allergy Clin Immunol Pract; 2017; 5(6):1519-1531. PubMed ID: 28970084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dupilumab: human monoclonal antibody against IL-4Rα for moderate to severe atopic dermatitis.
    Paton DM
    Drugs Today (Barc); 2017 Sep; 53(9):477-487. PubMed ID: 29238761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dupilumab: A review of its use in the treatment of atopic dermatitis.
    Gooderham MJ; Hong HC; Eshtiaghi P; Papp KA
    J Am Acad Dermatol; 2018 Mar; 78(3 Suppl 1):S28-S36. PubMed ID: 29471919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.
    Blauvelt A; de Bruin-Weller M; Gooderham M; Cather JC; Weisman J; Pariser D; Simpson EL; Papp KA; Hong HC; Rubel D; Foley P; Prens E; Griffiths CEM; Etoh T; Pinto PH; Pujol RM; Szepietowski JC; Ettler K; Kemény L; Zhu X; Akinlade B; Hultsch T; Mastey V; Gadkari A; Eckert L; Amin N; Graham NMH; Pirozzi G; Stahl N; Yancopoulos GD; Shumel B
    Lancet; 2017 Jun; 389(10086):2287-2303. PubMed ID: 28478972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and management of moderate to severe atopic dermatitis in adolescents. A Consensus by the Italian Society of Dermatology and Venereology (SIDeMaST), the Italian Association of Hospital Dermatologists and Public Health (ADOI), the Italian Association of Hospital and Territorial Allergists and Immunologists (AAIITO), the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC), the Italian Society of Pediatric Allergy and Immunology (SIAIP), the Italian Society of Allergological, Occupational and Environmental Dermatology (SIDAPA), and the Italian Society of Pediatric Dermatology (SIDerP).
    Calzavara-Pinton P; Belloni Fortina A; Bonamonte D; Marseglia GL; Miraglia Del Giudice M; Musarra A; Nettis E; Neri I; Patruno C; Stingeni L; Peris K;
    Ital J Dermatol Venerol; 2021 Apr; 156(2):184-197. PubMed ID: 32438781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate Mofetil in Severe Atopic Dermatitis: A Review.
    Prussick L; Plotnikova N; Gottlieb A
    J Drugs Dermatol; 2016 Jun; 15(6):715-8. PubMed ID: 27272078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic Agents for Severe Atopic Dermatitis in Children.
    Notaro ER; Sidbury R
    Paediatr Drugs; 2015 Dec; 17(6):449-57. PubMed ID: 26547214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of Systemic Treatment Options for Adult Atopic Dermatitis.
    Gooderham M; Lynde CW; Papp K; Bourcier M; Guenther L; Gulliver W; Hong CH; Poulin Y; Sussman G; Vender R
    J Cutan Med Surg; 2017; 21(1):31-39. PubMed ID: 27635033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic Treatment for Severe Atopic Dermatitis.
    Giavina-Bianchi M; Giavina-Bianchi P
    Arch Immunol Ther Exp (Warsz); 2019 Apr; 67(2):69-78. PubMed ID: 30159581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult atopic dermatitis: new and emerging therapies.
    Napolitano M; Marasca C; Fabbrocini G; Patruno C
    Expert Rev Clin Pharmacol; 2018 Sep; 11(9):867-878. PubMed ID: 30073901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient burden of moderate to severe atopic dermatitis (AD): Insights from a phase 2b clinical trial of dupilumab in adults.
    Simpson EL; Bieber T; Eckert L; Wu R; Ardeleanu M; Graham NM; Pirozzi G; Mastey V
    J Am Acad Dermatol; 2016 Mar; 74(3):491-8. PubMed ID: 26777100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal Antibodies for Atopic Dermatitis: Progress and Potential.
    Vakharia PP; Silverberg JI
    BioDrugs; 2017 Oct; 31(5):409-422. PubMed ID: 28853008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD).
    Simpson EL; Gadkari A; Worm M; Soong W; Blauvelt A; Eckert L; Wu R; Ardeleanu M; Graham NMH; Pirozzi G; Sutherland ER; Mastey V
    J Am Acad Dermatol; 2016 Sep; 75(3):506-515. PubMed ID: 27268421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and emerging biologics for the treatment of pediatric atopic dermatitis.
    Ghamrawi R; Bell KA; Balogh EA; Strowd LC; Feldman SR
    Expert Opin Biol Ther; 2020 Dec; 20(12):1435-1445. PubMed ID: 33078990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of whey associated with dodder seed extract on moderate-to-severe atopic dermatitis in adults: A randomized, double-blind, placebo-controlled clinical trial.
    Mehrbani M; Choopani R; Fekri A; Mehrabani M; Mosaddegh M; Mehrabani M
    J Ethnopharmacol; 2015 Aug; 172():325-32. PubMed ID: 26151244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Past, present, and future for biologic intervention in atopic dermatitis.
    Howell MD; Parker ML; Mustelin T; Ranade K
    Allergy; 2015 Aug; 70(8):887-96. PubMed ID: 25879391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term management of moderate-to-severe adult atopic dermatitis: a consensus by the Italian Society of Dermatology and Venereology (SIDeMaST), the Association of Italian Territorial and Hospital Allergists and Immunologists (AAIITO), the Italian Association of Hospital Dermatologists (ADOI), the Italian Society of Allergological, Environmental and Occupational Dermatology (SIDAPA), and the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC).
    Costanzo A; Amerio P; Asero R; Chiricozzi A; Corazza M; Cristaudo A; Cusano F; Ferrucci SM; Nettis E; Patrizi A; Patruno C; Peris K; Picozza M; Stingeni L; Girolomoni G;
    Ital J Dermatol Venerol; 2022 Feb; 157(1):1-12. PubMed ID: 34929995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic Evaluation of Dupilumab for Moderate-to-Severe Atopic Dermatitis: A Cost-Utility Analysis.
    Zimmermann M; Rind D; Chapman R; Kumar V; Kahn S; Carlson J
    J Drugs Dermatol; 2018 Jul; 17(7):750-756. PubMed ID: 30005097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.